Vietnam
Industry
It is BMI's view that corruption is a significant problem in Vietnam. The payment of bribes increases transaction costs, diverting resources away from more productive uses. The ultimate...
2010-04-01Industry
A common feature of emerging markets is a preference for foreign pharmaceuticals over domestically-produced equivalents. Imported medicines are perceived as being of higher quality...
2010-02-02Industry
Vietnam's new Law on Health Insurance is causing public discontent. Many people on low incomes cannot afford the co-payments and are forgoing check-ups and treatment. BMI believes...
2010-01-22Industry
The Hanoi University of Pharmacy is to produce Fludon H1 (arbidol) in 2010 to combat swine flu. This development is significant because the medicine is underappreciated in developed...
2009-12-02Industry
Corruption is endemic in Vietnam's US$5.79bn healthcare system. Patients pay doctors and nurses to avoid waiting lists and receive above-average care. Those on low incomes that cannot...
2009-09-25Industry
Vietnam's US$1.4bn pharmaceutical market is one of the most promising in the Asia Pacific region. Annual per-capita spending is low (US$16.13) and growth is high - BMI is forecasting...
2009-08-28Industry
Vietnam has introduced its first domestically-produced measles vaccine. This means the South East Asian country's 10-vaccine National Expanded Immunisation Programme (NEIP) is now...
2009-07-02Industry
The Drug Controller General of India has approved the first affordable cholera vaccine. This will reduce the burden of the deadly disease and therefore stimulate the US$1.2trn economy....
2009-04-22
